L Idolazzi1, M El Ghoch2, R Dalle Grave2, P V Bazzani2, S Calugi2, S Fassio3, C Caimmi3, O Viapiana3, F Bertoldo4, V Braga3, M Rossini3, D Gatti3. 1. Unit of Rheumatology, University of Verona, P.le L. Scuro 2, 37134, Verona, Italy. luca.idolazzi@univr.it. 2. Department of Eating and Weight Disorders, Villa Garda Hospital, Via Montebaldo, 89, Garda, 37016, Verona, Italy. 3. Unit of Rheumatology, University of Verona, P.le L. Scuro 2, 37134, Verona, Italy. 4. Internal Medicine, University of Verona, P.le L. Scuro 2, 37134, Verona, Italy.
Abstract
PURPOSE: Aim of this study is focusing on bone metabolism in AN patients with amenorrhoea and related estrogen deficiency effects. METHODS: AN patients were compared both with healthy females and with postmenopausal women (reference model for estrogen deficiency). The study sample included 81 females with AN. Laboratory tests [25-OH vitamin D, bone turnover markers, intact parathyroid hormone, sclerostin (SOST) and dickkopf-related protein (DKK1)] and dual energy X-ray absorptiometry (DXA) were taken into account. RESULTS: AN patients had higher levels of C-terminal telopeptide of type I collagen (CTX) than both control groups. AN adolescents had CTX higher than AN young adults. In postmenopausal women, intact N-propeptide of type I collagen was higher if compared with each other group. In AN groups, Dickkopf-related protein 1 was significantly lower than the two control groups. No differences were found in sclerostin except in adolescents. In AN adolescents, DXA values at femoral sites were higher than in AN young adults and a positive correlation was found with body weight (p < 0.01) and with fat mass evaluated using DXA (p < 0.01). CONCLUSIONS: AN women with amenorrhoea have an increased bone resorption like postmenopausal women but bone formation is depressed. The consequent remodeling uncoupling is considerably more severe than that occurring after menopause.
PURPOSE: Aim of this study is focusing on bone metabolism in AN patients with amenorrhoea and related estrogen deficiency effects. METHODS: AN patients were compared both with healthy females and with postmenopausal women (reference model for estrogen deficiency). The study sample included 81 females with AN. Laboratory tests [25-OH vitamin D, bone turnover markers, intact parathyroid hormone, sclerostin (SOST) and dickkopf-related protein (DKK1)] and dual energy X-ray absorptiometry (DXA) were taken into account. RESULTS: AN patients had higher levels of C-terminal telopeptide of type I collagen (CTX) than both control groups. AN adolescents had CTX higher than AN young adults. In postmenopausal women, intact N-propeptide of type I collagen was higher if compared with each other group. In AN groups, Dickkopf-related protein 1 was significantly lower than the two control groups. No differences were found in sclerostin except in adolescents. In AN adolescents, DXA values at femoral sites were higher than in AN young adults and a positive correlation was found with body weight (p < 0.01) and with fat mass evaluated using DXA (p < 0.01). CONCLUSIONS: AN women with amenorrhoea have an increased bone resorption like postmenopausal women but bone formation is depressed. The consequent remodeling uncoupling is considerably more severe than that occurring after menopause.
Entities:
Keywords:
Anorexia nervosa; Body composition; Bone turnover markers; DKK-1; Sclerostin
Authors: Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman Journal: Cell Date: 2001-11-16 Impact factor: 41.582
Authors: Neville H Golden; Elba A Iglesias; Marc S Jacobson; Dennis Carey; Wendy Meyer; Janet Schebendach; Stanley Hertz; I Ronald Shenker Journal: J Clin Endocrinol Metab Date: 2005-03-22 Impact factor: 5.958
Authors: Lynn M Boyden; Junhao Mao; Joseph Belsky; Lyle Mitzner; Anita Farhi; Mary A Mitnick; Dianqing Wu; Karl Insogna; Richard P Lifton Journal: N Engl J Med Date: 2002-05-16 Impact factor: 91.245
Authors: S Grinspoon; K Miller; C Coyle; J Krempin; C Armstrong; S Pitts; D Herzog; A Klibanski Journal: J Clin Endocrinol Metab Date: 1999-06 Impact factor: 5.958
Authors: M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan Journal: Am J Hum Genet Date: 2001-02-09 Impact factor: 11.025
Authors: Catherine M Gordon; Elizabeth Goodman; S Jean Emans; Estherann Grace; Kelly A Becker; Clifford J Rosen; Caren M Gundberg; Meryl S Leboff Journal: J Pediatr Date: 2002-07 Impact factor: 4.406
Authors: Leslie A Soyka; Madhusmita Misra; Aparna Frenchman; Karen K Miller; Steven Grinspoon; David A Schoenfeld; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2002-09 Impact factor: 5.958
Authors: Karen K Miller; Kelly A Grieco; Jean Mulder; Steven Grinspoon; Diane Mickley; Revital Yehezkel; David B Herzog; Anne Klibanski Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958
Authors: Anna Svedlund; Cecilia Pettersson; Bojan Tubic; Lars Ellegård; Anders Elfvin; Per Magnusson; Diana Swolin-Eide Journal: J Bone Miner Metab Date: 2022-08-12 Impact factor: 2.976